{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:21:23Z","timestamp":1791822083467,"version":"4.3.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/nrneph.2011.168","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T16:53:48Z","timestamp":1320166428000},"page":"43-51","source":"Crossref","is-referenced-by-count":250,"title":["The pathogenesis and diagnosis of acute kidney injury in multiple myeloma"],"prefix":"10.1038","volume":"8","author":[{"name":"on behalf of the International Kidney and Monoclonal Gammopathy Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin A.","family":"Hutchison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vecihi","family":"Batuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bridoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Sirac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo A.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"BFnrneph2011168_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/jcp.25.6.555-d","volume":"25","author":"R Peto","year":"1972","unstructured":"Peto, R. Factors of prognostic significance in myelomatosis. J. Clin. Pathol. 25, 555 (1972).","journal-title":"J. Clin. Pathol."},{"key":"BFnrneph2011168_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/ndt\/gfp488","volume":"25","author":"RJ Haynes","year":"2010","unstructured":"Haynes, R. J., Read, S., Collins, G. P., Darby, S. C. & Winearls, C. G. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrol. Dial. Transplant. 25, 419\u2013426 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011168_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","volume":"158","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9, J. et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch. Intern. Med. 158, 1889\u20131893 (1998).","journal-title":"Arch. Intern. Med."},{"key":"BFnrneph2011168_CR4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ki.2008.108","volume":"73","author":"N Leung","year":"2008","unstructured":"Leung, N. et al. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 73, 1282\u20131288 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2215\/CJN.04590908","volume":"4","author":"CA Hutchison","year":"2009","unstructured":"Hutchison, C. A. et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin. J. Am. Soc. Nephrol. 4, 745\u2013754 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011168_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1681\/ASN.2010080857","volume":"22","author":"CA Hutchison","year":"2011","unstructured":"Hutchison, C. A. et al. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J. Am. Soc. Nephrol. 22, 1129\u20131136 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011168_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1182\/blood-2005-03-1186","volume":"107","author":"A Arimura","year":"2006","unstructured":"Arimura, A., Li, M. & Batuman, V. Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury. Blood 107, 661\u2013668 (2006).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR8","first-page":"F1259","volume":"258","author":"V Batuman","year":"1990","unstructured":"Batuman, V., Dreisbach, A. W. & Cyran, J. Light-chain binding sites on renal brush-border membranes. Am. J. Physiol. 258, F1259\u2013F1265 (1990).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph2011168_CR9","first-page":"F521","volume":"272","author":"V Batuman","year":"1997","unstructured":"Batuman, V. & Guan, S. Receptor-mediated endocytosis of immunoglobulin light chains by renal proximal tubule cells. Am. J. Physiol. 272, F521\u2013F530 (1997).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph2011168_CR10","first-page":"294","volume":"17","author":"V Batuman","year":"1994","unstructured":"Batuman, V., Guan, S., O'Donovan, R. & Puschett, J. B. Effect of myeloma light chains on phosphate and glucose transport in renal proximal tubule cells. Ren. Physiol. Biochem. 17, 294\u2013300 (1994).","journal-title":"Ren. Physiol. Biochem."},{"key":"BFnrneph2011168_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/ki.1986.237","volume":"30","author":"V Batuman","year":"1986","unstructured":"Batuman, V., Sastrasinh, M. & Sastrasinh, S. Light chain effects on alanine and glucose uptake by renal brush border membranes. Kidney Int. 30, 662\u2013665 (1986).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR12","first-page":"F246","volume":"275","author":"V Batuman","year":"1998","unstructured":"Batuman, V. et al. Myeloma light chains are ligands for cubilin (gp280). Am. J. Physiol. 275, F246\u2013F254 (1998).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph2011168_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1152\/japplphysiol.01090.2003","volume":"98","author":"RB Klassen","year":"2005","unstructured":"Klassen, R. B., Allen, P. L., Batuman, V., Crenshaw, K. & Hammond, T. G. Light chains are a ligand for megalin. J. Appl. Physiol. 98, 257\u2013263 (2005).","journal-title":"J. Appl. Physiol."},{"key":"BFnrneph2011168_CR14","doi-asserted-by":"publisher","first-page":"F82","DOI":"10.1152\/ajprenal.00091.2008","volume":"295","author":"M Li","year":"2008","unstructured":"Li, M., Balamuthusamy, S., Simon, E. E. & Batuman, V. Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cells. Am. J. Physiol. Renal Physiol. 295, F82\u2013F90 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2011168_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/ndt\/gfm670","volume":"23","author":"M Li","year":"2008","unstructured":"Li, M., Hering-Smith, K. S., Simon, E. E. & Batuman, V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transplant. 23, 860\u2013870 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011168_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1053\/ajkd.2000.17620","volume":"36","author":"A Pote","year":"2000","unstructured":"Pote, A., Zwizinski, C., Simon, E. E., Meleg-Smith, S. & Batuman, V. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am. J. Kidney Dis. 36, 735\u2013744 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2011168_CR17","doi-asserted-by":"publisher","first-page":"F1245","DOI":"10.1152\/ajprenal.00350.2002","volume":"284","author":"S Sengul","year":"2003","unstructured":"Sengul, S., Zwizinski, C. & Batuman, V. Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells. Am. J. Physiol. Renal Physiol. 284, F1245\u2013F1254 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2011168_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1046\/j.1523-1755.2002.00660.x","volume":"62","author":"S Sengul","year":"2002","unstructured":"Sengul, S. et al. Endocytosis of light chains induces cytokines through activation of NF-\u03baB in human proximal tubule cells. Kidney Int. 62, 1977\u20131988 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR19","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1172\/JCI113830","volume":"82","author":"PW Sanders","year":"1988","unstructured":"Sanders, P. W., Herrera, G. A., Chen, A., Booker, B. B. & Galla, J. H. Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J. Clin. Invest. 82, 2086\u20132096 (1988).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011168_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1172\/JCI114474","volume":"85","author":"PW Sanders","year":"1990","unstructured":"Sanders, P. W., Booker, B. B., Bishop, J. B. & Cheung, H. C. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J. Clin. Invest. 85, 570\u2013576 (1990).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011168_CR21","first-page":"527","volume":"64","author":"PW Sanders","year":"1991","unstructured":"Sanders, P. W., Herrera, G. A., Kirk, K. A., Old, C. W. & Galla, J. H. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab. Invest. 64, 527\u2013537 (1991).","journal-title":"Lab. Invest."},{"key":"BFnrneph2011168_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1172\/JCI115629","volume":"89","author":"PW Sanders","year":"1992","unstructured":"Sanders, P. W. & Booker, B. B. Pathobiology of cast nephropathy from human Bence Jones proteins. J. Clin. Invest. 89, 630\u2013639 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011168_CR23","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1172\/JCI116920","volume":"92","author":"ZQ Huang","year":"1993","unstructured":"Huang, Z. Q., Kirk, K. A., Connelly, K. G. & Sanders, P. W. Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation. J. Clin. Invest. 92, 2975\u20132983 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011168_CR24","first-page":"324","volume":"13","author":"PW Sanders","year":"1993","unstructured":"Sanders, P. W. & Herrera, G. A. Monoclonal immunoglobulin light chain-related renal diseases. Semin. Nephrol. 13, 324\u2013341 (1993).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph2011168_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1172\/JCI119218","volume":"99","author":"ZQ Huang","year":"1997","unstructured":"Huang, Z. Q. & Sanders, P. W. Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein. J. Clin. Invest. 99, 732\u2013736 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011168_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0002-9440(10)64142-9","volume":"158","author":"WZ Ying","year":"2001","unstructured":"Ying, W. Z. & Sanders, P. W. Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein. Am. J. Pathol. 158, 1859\u20131866 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2011168_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000096763","volume":"153","author":"GA Herrera","year":"2007","unstructured":"Herrera, G. A. & Sanders, P. W. Paraproteinemic renal diseases that involve the tubulo-interstitium. Contrib. Nephrol. 153, 105\u2013115 (2007).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph2011168_CR28","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1681\/ASN.2006111299","volume":"18","author":"PX Wang","year":"2007","unstructured":"Wang, P. X. & Sanders, P. W. Immunoglobulin light chains generate hydrogen peroxide. J. Am. Soc. Nephrol. 18, 1239\u20131245 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011168_CR29","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1681\/ASN.2009101089","volume":"21","author":"K Basnayake","year":"2010","unstructured":"Basnayake, K., Ying, W. Z., Wang, P. X. & Sanders, P. W. Immunoglobulin light chains activate tubular epithelial cells through redox signaling. J. Am. Soc. Nephrol. 21, 1165\u20131173 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011168_CR30","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1182\/blood-2010-08-302505","volume":"117","author":"WZ Ying","year":"2011","unstructured":"Ying, W. Z., Wang, P. X., Aaron, K. J., Basnayake, K. & Sanders, P. W. Immunoglobulin light chains activate NF-\u03baB in renal epithelial cells through a Src-dependent mechanism. Blood 117, 1301\u20131307 (2011).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ki.1985.8","volume":"27","author":"MD Holland","year":"1985","unstructured":"Holland, M. D., Galla, J. H., Sanders, P. W. & Luke, R. G. Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney Int. 27, 46\u201350 (1985).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR32","first-page":"810","volume":"73","author":"ZQ Huang","year":"1995","unstructured":"Huang, Z. Q. & Sanders, P. W. Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy. Lab. Invest. 73, 810\u2013817 (1995).","journal-title":"Lab. Invest."},{"key":"BFnrneph2011168_CR33","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJM199106273242603","volume":"324","author":"A Solomon","year":"1991","unstructured":"Solomon, A., Weiss, D. T. & Kattine, A. A. Nephrotoxic potential of Bence Jones proteins. N. Engl. J. Med. 324, 1845\u20131851 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011168_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0140-6736(02)86528-X","volume":"50","author":"H Bence Jones","year":"1847","unstructured":"Bence Jones, H. Papers on clinical pathology. Lancet 50, 88\u201392 (1847).","journal-title":"Lancet"},{"key":"BFnrneph2011168_CR35","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/S0021-9258(18)94320-6","volume":"244","author":"I Bergg\u00e5rd","year":"1969","unstructured":"Bergg\u00e5rd, I. & Peterson, P. A. Polymeric forms of free normal \u03ba and \u03bb chains of human immunoglobulin. J. Biol. Chem. 244, 4299\u20134307 (1969).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2011168_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05045.x","volume":"126","author":"GP Mead","year":"2004","unstructured":"Mead, G. P. et al. Serum free light chains for monitoring multiple myeloma. Br. J. Haematol. 126, 348\u2013354 (2004).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph2011168_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00125480-200401000-00005","volume":"11","author":"GS Markowitz","year":"2004","unstructured":"Markowitz, G. S. Dysproteinemia and the kidney. Adv. Anat. Pathol. 11, 49\u201363 (2004).","journal-title":"Adv. Anat. Pathol."},{"key":"BFnrneph2011168_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ki.1987.286","volume":"32","author":"PW Sanders","year":"1987","unstructured":"Sanders, P. W., Herrera, G. A. & Galla, J. H. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int. 32, 851\u2013861 (1987).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000416513","volume":"68","author":"JH Galla","year":"1988","unstructured":"Galla, J. H., Herrera, G. A. & Sanders, P. W. Differential toxicity of human Bence-Jones proteins in the rat proximal convoluted tubule in vivo. Contrib. Nephrol. 68, 198\u2013202 (1988).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph2011168_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ki.1988.80","volume":"33","author":"PW Sanders","year":"1988","unstructured":"Sanders, P. W., Herrera, G. A., Lott, R. L. & Galla, J. H. Morphologic alterations of the proximal tubules in light chain-related renal disease. Kidney Int. 33, 881\u2013889 (1988).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR41","first-page":"496","volume":"47","author":"S Guan","year":"1999","unstructured":"Guan, S., el-Dahr, S., Dipp, S. & Batuman, V. Inhibition of Na-K-ATPase activity and gene expression by a myeloma light chain in proximal tubule cells. J. Investig. Med. 47, 496\u2013501 (1999).","journal-title":"J. Investig. Med."},{"key":"BFnrneph2011168_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000096762","volume":"153","author":"V Batuman","year":"2007","unstructured":"Batuman, V. Proximal tubular injury in myeloma. Contrib. Nephrol. 153, 87\u2013104 (2007).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph2011168_CR43","first-page":"17","volume":"22","author":"S Sengul","year":"2009","unstructured":"Sengul, S., Li, M. & Batuman, V. Myeloma kidney: toward its prevention\u2014with new insights from in vitro and in vivo models of renal injury. J. Nephrol. 22, 17\u201328 (2009).","journal-title":"J. Nephrol."},{"key":"BFnrneph2011168_CR44","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1159\/000317129","volume":"116","author":"AM Khan","year":"2010","unstructured":"Khan, A. M. et al. Myeloma light chain-induced renal injury in mice. Nephron Exp. Nephrol. 116, e32\u2013e41 (2010).","journal-title":"Nephron Exp. Nephrol."},{"key":"BFnrneph2011168_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0002-9343(75)90601-4","volume":"58","author":"JE Maldonado","year":"1975","unstructured":"Maldonado, J. E. et al. Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am. J. Med. 58, 354\u2013364 (1975).","journal-title":"Am. J. Med."},{"key":"BFnrneph2011168_CR46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ki.2008.666","volume":"76","author":"LC Herlitz","year":"2009","unstructured":"Herlitz, L. C., Roglieri, J., Resta, R., Bhagat, G. & Markowitz, G. S. Light chain proximal tubulopathy. Kidney Int. 76, 792\u2013797 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ki.1981.122","volume":"20","author":"JH Weiss","year":"1981","unstructured":"Weiss, J. H. et al. Pathophysiology of acute Bence-Jones protein nephrotoxicity in the rat. Kidney Int. 20, 198\u2013210 (1981).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR48","first-page":"F77","volume":"250","author":"GA Tanner","year":"1986","unstructured":"Tanner, G. A. & Knopp, L. C. Glomerular blood flow after single nephron obstruction in the rat kidney. Am. J. Physiol. 250, F77\u2013F85 (1986).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph2011168_CR49","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ki.1989.300","volume":"36","author":"GA Tanner","year":"1989","unstructured":"Tanner, G. A. & Evan, A. P. Glomerular and proximal tubular morphology after single nephron obstruction. Kidney Int. 36, 1050\u20131060 (1989).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR50","first-page":"336","volume":"1","author":"DA Start","year":"1988","unstructured":"Start, D. A., Silva, F. G., Davis, L. D., D'Agati, V. & Pirani, C. L. Myeloma cast nephropathy: immunohistochemical and lectin studies. Mod. Pathol. 1, 336\u2013347 (1988).","journal-title":"Mod. Pathol."},{"key":"BFnrneph2011168_CR51","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1046\/j.1523-1755.1998.00117.x","volume":"54","author":"WZ Ying","year":"1998","unstructured":"Ying, W. Z. & Sanders, P. W. Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats. Kidney Int. 54, 1150\u20131156 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph2011168_CR52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1445-5994.1977.tb03359.x","volume":"7","author":"R Woodruff","year":"1977","unstructured":"Woodruff, R. & Sweet, B. Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function. Aust. NZ J. Med. 7, 60\u201362 (1977).","journal-title":"Aust. NZ J. Med."},{"key":"BFnrneph2011168_CR53","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1182\/blood.V86.10.3655.bloodjournal86103655","volume":"86","author":"AA Khamlichi","year":"1995","unstructured":"Khamlichi, A. A. et al. Role of light chain variable region in myeloma with light chain deposition disease: evidence from an experimental model. Blood 86, 3655\u20133659 (1995).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR54","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood.V94.10.3559.422k10_3559_3566","volume":"94","author":"C Decourt","year":"1999","unstructured":"Decourt, C. et al. Mutational analysis in murine models for myeloma-associated Fanconi's syndrome or cast myeloma nephropathy. Blood 94, 3559\u20133566 (1999).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR55","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood-2005-11-4419","volume":"108","author":"C Sirac","year":"2006","unstructured":"Sirac, C. et al. Role of the monoclonal \u03ba chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood 108, 536\u2013543 (2006).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR56","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1073\/pnas.91.8.3034","volume":"91","author":"EA Myatt","year":"1994","unstructured":"Myatt, E. A. et al. Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition. Proc. Natl Acad. Sci. USA 91, 3034\u20133038 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2011168_CR57","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.4049\/jimmunol.150.8.3561","volume":"150","author":"P Aucouturier","year":"1993","unstructured":"Aucouturier, P. et al. Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J. Immunol. 150, 3561\u20133568 (1993).","journal-title":"J. Immunol."},{"key":"BFnrneph2011168_CR58","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.155.6.3245","volume":"155","author":"A Rocca","year":"1995","unstructured":"Rocca, A. et al. Sequences of V kappa L subgroup light chains in Fanconi's syndrome. Light chain V region gene usage restriction and peculiarities in myeloma-associated Fanconi's syndrome. J. Immunol. 155, 3245\u20133252 (1995).","journal-title":"J. Immunol."},{"key":"BFnrneph2011168_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","volume":"79","author":"T Messiaen","year":"2000","unstructured":"Messiaen, T. et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore) 79, 135\u2013154 (2000).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph2011168_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/protein\/12.4.363","volume":"12","author":"S D\u00e9ret","year":"1999","unstructured":"D\u00e9ret, S. et al. Kappa light chain-associated Fanconi's syndrome: molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals. Protein Eng. 12, 363\u2013369 (1999).","journal-title":"Protein Eng."},{"key":"BFnrneph2011168_CR61","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1182\/blood.V98.3.714","volume":"98","author":"RL Comenzo","year":"2001","unstructured":"Comenzo, R. L., Zhang, Y., Martinez, C., Osman, K. & Herrera, G. A. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig VL germ line gene use and clonal plasma cell burden. Blood 98, 714\u2013720 (2001).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-2478(94)90036-1","volume":"42","author":"L Denoroy","year":"1994","unstructured":"Denoroy, L., D\u00e9ret, S. & Aucouturier, P. Overrepresentation of the V kappa IV subgroup in light chain deposition disease. Immunol. Lett. 42, 63\u201366 (1994).","journal-title":"Immunol. Lett."},{"key":"BFnrneph2011168_CR63","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1172\/JCI115252","volume":"87","author":"M Cogn\u00e9","year":"1991","unstructured":"Cogn\u00e9, M., Preud'homme, J. L., Bauwens, M., Touchard, G. & Aucouturier, P. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease. J. Clin. Invest. 87, 2186\u20132190 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011168_CR64","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/13506120009146835","volume":"7","author":"FJ Stevens","year":"2000","unstructured":"Stevens, F. J. Four structural risk factors identify most fibril-forming kappa light chains. Amyloid 7, 200\u2013211 (2000).","journal-title":"Amyloid"},{"key":"BFnrneph2011168_CR65","doi-asserted-by":"publisher","first-page":"e981","DOI":"10.1371\/journal.pone.0000981","volume":"2","author":"S Enqvist","year":"2007","unstructured":"Enqvist, S., Sletten, K., Stevens, F. J., Hellman, U. & Westermark, P. Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis. PLoS ONE 2, e981 (2007).","journal-title":"PLoS ONE"},{"key":"BFnrneph2011168_CR66","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/protein\/10.10.1191","volume":"10","author":"S D\u00e9ret","year":"1997","unstructured":"D\u00e9ret, S. et al. Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. Protein Eng. 10, 1191\u20131197 (1997).","journal-title":"Protein Eng."},{"key":"BFnrneph2011168_CR67","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/prot.21934","volume":"72","author":"L del Pozo Yauner","year":"2008","unstructured":"del Pozo Yauner, L. et al. Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains. Proteins 72, 684\u2013692 (2008).","journal-title":"Proteins"},{"key":"BFnrneph2011168_CR68","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/pro.5560040309","volume":"4","author":"PW Stevens","year":"1995","unstructured":"Stevens, P. W. et al. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Protein Sci. 4, 421\u2013432 (1995).","journal-title":"Protein Sci."},{"key":"BFnrneph2011168_CR69","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1365-2141.2008.07522.x","volume":"144","author":"B Kaplan","year":"2009","unstructured":"Kaplan, B. et al. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease. Br. J. Haematol. 144, 705\u2013715 (2009).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph2011168_CR70","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2141.2006.06488.x","volume":"136","author":"B Kaplan","year":"2007","unstructured":"Kaplan, B., Livneh, A. & Gallo, G. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease. Br. J. Haematol. 136, 723\u2013728 (2007).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph2011168_CR71","doi-asserted-by":"publisher","first-page":"9848","DOI":"10.1021\/bi101351c","volume":"49","author":"ES Klimtchuk","year":"2010","unstructured":"Klimtchuk, E. S. et al. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain. Biochemistry 49, 9848\u20139857 (2010).","journal-title":"Biochemistry"},{"key":"BFnrneph2011168_CR72","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1016\/j.febslet.2010.06.019","volume":"584","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto, K. et al. The amyloid fibrils of the constant domain of immunoglobulin light chain. FEBS Lett. 584, 3348\u20133353 (2010).","journal-title":"FEBS Lett."},{"key":"BFnrneph2011168_CR73","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/labinvest.3700161","volume":"84","author":"J Keeling","year":"2004","unstructured":"Keeling, J., Teng, J. & Herrera, G. A. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab. Invest. 84, 1322\u20131338 (2004).","journal-title":"Lab. Invest."},{"key":"BFnrneph2011168_CR74","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1136\/jcp.2010.079236","volume":"63","author":"K Basnayake","year":"2010","unstructured":"Basnayake, K. et al. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. J. Clin. Pathol. 63, 884\u2013887 (2010).","journal-title":"J. Clin. Pathol."},{"key":"BFnrneph2011168_CR75","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","volume":"47","author":"AR Bradwell","year":"2001","unstructured":"Bradwell, A. R. et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin. Chem. 47, 673\u2013680 (2001).","journal-title":"Clin. Chem."},{"key":"BFnrneph2011168_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2369-9-11","volume":"9","author":"CA Hutchison","year":"2008","unstructured":"Hutchison, C. A. et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol. 9, 11 (2008).","journal-title":"BMC Nephrol."},{"key":"BFnrneph2011168_CR77","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann, J. A. et al. Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin. Chem. 48, 1437\u20131444 (2002).","journal-title":"Clin. Chem."},{"key":"BFnrneph2011168_CR78","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrneph.2009.151","volume":"5","author":"CA Hutchison","year":"2009","unstructured":"Hutchison, C. A., Basnayake, K. & Cockwell, P. Serum free light chain assessment in monoclonal gammopathy and kidney disease. Nat. Rev. Nephrol. 5, 621\u2013628 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2011168_CR79","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","volume":"55","author":"JA Katzmann","year":"2009","unstructured":"Katzmann, J. A. et al. Screening panels for detection of monoclonal gammopathies. Clin. Chem. 55, 1517\u20131522 (2009).","journal-title":"Clin. Chem."},{"key":"BFnrneph2011168_CR80","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BG Durie","year":"2006","unstructured":"Durie, B. G. et al. on behalf of the International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia 20, 1467\u20131473 (2006).","journal-title":"Leukemia"},{"key":"BFnrneph2011168_CR81","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/leu.2008.307","volume":"23","author":"A Dispenzieri","year":"2009","unstructured":"Dispenzieri, A. et al. on behalf of the International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 23, 215\u2013224 (2009).","journal-title":"Leukemia"},{"key":"BFnrneph2011168_CR82","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2215\/CJN.02290508","volume":"3","author":"CA Hutchison","year":"2008","unstructured":"Hutchison, C. A. et al. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1684\u20131690 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011168_CR83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5858\/133.2.249","volume":"133","author":"GA Herrera","year":"2009","unstructured":"Herrera, G. A. Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges. Arch. Pathol. Lab. Med. 133, 249\u2013267 (2009).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrneph2011168_CR84","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1092-9134(00)90042-X","volume":"4","author":"GA Herrera","year":"2000","unstructured":"Herrera, G. A. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory. Ann. Diagn. Pathol. 4, 174\u2013200 (2000).","journal-title":"Ann. Diagn. Pathol."},{"key":"BFnrneph2011168_CR85","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1681\/ASN.2006020139","volume":"17","author":"SM Korbet","year":"2006","unstructured":"Korbet, S. M. & Schwartz, M. M. Multiple myeloma. J. Am. Soc. Nephrol. 17, 2533\u20132545 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011168_CR86","first-page":"853","volume-title":"Heptinstall's Pathology of the Kidney","author":"GA Herrera","year":"2006","unstructured":"Herrera, G. A. & Picken, M. M. in Heptinstall's Pathology of the Kidney (eds Jennette, J. C., Olson, J. L. & Schwartz, M. M.) 853\u2013910 (Lippincott-Raven, Philadelphia, 2006)."},{"key":"BFnrneph2011168_CR87","first-page":"345","volume-title":"Silva's Diagnostic Renal Pathology","author":"GA Herrera","year":"2009","unstructured":"Herrera, G. A. in Silva's Diagnostic Renal Pathology (eds Zhou, X. J., Laszik, Z., Nadasdy, T., D'Agati, V. D. & Silva, F.) 345\u2013406 (Cambridge University Press, Cambridge, 2009)."},{"key":"BFnrneph2011168_CR88","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.5858\/2007-131-1368-ETPSOI","volume":"131","author":"U Kapur","year":"2007","unstructured":"Kapur, U., Barton, K., Fresco, R., Leehey, D. J. & Picken, M. M. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Arch. Pathol. Lab. Med. 131, 1368\u20131372 (2007).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrneph2011168_CR89","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","volume":"43","author":"N Leung","year":"2004","unstructured":"Leung, N. et al. Long-term outcome of renal transplantation in light-chain deposition disease. Am. J. Kidney Dis. 43, 147\u2013153 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2011168_CR90","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000046254","volume":"21","author":"AK Short","year":"2001","unstructured":"Short, A. K., O'Donoghue, D. J., Riad, H. N., Short, C. D. & Roberts, I. S. Recurrence of light chain nephropathy in a renal allograft. A case report and review of the literature. Am. J. Nephrol. 21, 237\u2013240 (2001).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2011168_CR91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5858\/2006-130-165-LATINA","volume":"130","author":"X Gu","year":"2006","unstructured":"Gu, X. & Herrera, G. A. Light-chain-mediated acute tubular interstitial nephritis: a poorly recognized pattern of renal disease in patients with plasma cell dyscrasia. Arch. Pathol. Lab. Med. 130, 165\u2013169 (2006).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrneph2011168_CR92","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1159\/000064299","volume":"91","author":"J Isaac","year":"2002","unstructured":"Isaac, J. & Herrera, G. A. Cast nephropathy in a case of Waldenstr\u00f6m's macroglobulinemia. Nephron 91, 512\u2013515 (2002).","journal-title":"Nephron"},{"key":"BFnrneph2011168_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s007950100000","volume":"34","author":"GA Herrera","year":"2001","unstructured":"Herrera, G. A. The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions. Med. Electron Microsc. 34, 1\u201318 (2001).","journal-title":"Med. Electron Microsc."},{"key":"BFnrneph2011168_CR94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/01913121003672873","volume":"34","author":"GA Herrera","year":"2010","unstructured":"Herrera, G. A. & Turbat-Herrera, E. A. Ultrastructural immunolabeling in the diagnosis of monoclonal light-and heavy-chain-related renal diseases. Ultrastruct. Pathol. 34, 161\u2013173 (2010).","journal-title":"Ultrastruct. Pathol."},{"key":"BFnrneph2011168_CR95","doi-asserted-by":"crossref","first-page":"850","DOI":"10.5858\/2007-131-850-TBOSAT","volume":"131","author":"MM Picken","year":"2007","unstructured":"Picken, M. M. & Herrera, G. A. The burden of \u201csticky\u201d amyloid: typing challenges. Arch. Pathol. Lab. Med. 131, 850\u2013851 (2007).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrneph2011168_CR96","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2215\/CJN.02890310","volume":"5","author":"S Sethi","year":"2010","unstructured":"Sethi, S. et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin. J. Am. Soc. Nephrol. 5, 2180\u20132187 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011168_CR97","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/ndt\/13.6.1438","volume":"13","author":"JJ Montseny","year":"1998","unstructured":"Montseny, J. J. et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol. Dial. Transplant. 13, 1438\u20131445 (1998).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011168_CR98","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1016\/S0272-6386(00)70221-6","volume":"35","author":"A Komatsuda","year":"2000","unstructured":"Komatsuda, A. et al. Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy. Am. J. Kidney Dis. 35, E9 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2011168_CR99","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1159\/000064296","volume":"91","author":"O Hotta","year":"2002","unstructured":"Hotta, O. & Taguma, Y. Resolution of nodular glomerular lesions in a patient with light-chain nephropathy. Nephron 91, 504\u2013505 (2002).","journal-title":"Nephron"},{"key":"BFnrneph2011168_CR100","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0268-960X(99)90014-0","volume":"13","author":"AD Clark","year":"1999","unstructured":"Clark, A. D., Shetty, A. & Soutar, R. Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma. Blood Rev. 13, 79\u201390 (1999).","journal-title":"Blood Rev."},{"key":"BFnrneph2011168_CR101","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ndt\/gfi318","volume":"21","author":"M Haubitz","year":"2006","unstructured":"Haubitz, M. & Peest, D. Myeloma\u2014new approaches to combined nephrological-haematological management. Nephrol. Dial. Transplant. 21, 582\u2013590 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011168_CR102","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1525-139X.2006.00181.x","volume":"19","author":"JG Penfield","year":"2006","unstructured":"Penfield, J. G. Multiple myeloma in end-stage renal disease. Semin. Dial. 19, 329\u2013334 (2006).","journal-title":"Semin. Dial."},{"key":"BFnrneph2011168_CR103","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2009-06-225854","volume":"114","author":"GP Mead","year":"2009","unstructured":"Mead, G. P. & Drayson, M. T. Sensitivity of serum free light chain measurement of residual disease in multiple myeloma patients. Blood 114, 1717 (2009).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR104","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2006-03-008953","volume":"108","author":"M Drayson","year":"2006","unstructured":"Drayson, M. et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials. Blood 108, 2013\u20132019 (2006).","journal-title":"Blood"},{"key":"BFnrneph2011168_CR105","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MNH.0b013e32833ef72c","volume":"19","author":"P Cockwell","year":"2010","unstructured":"Cockwell, P. & Hutchison, C. A. Management options for cast nephropathy in multiple myeloma. Curr. Opin. Nephrol. Hypertens. 19, 550\u2013555 (2010).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2011168_CR106","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2141.2008.07079.x","volume":"141","author":"G Pratt","year":"2008","unstructured":"Pratt, G. The evolving use of serum free light chain assays in haematology. Br. J. Haematol. 141, 413\u2013422 (2008).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph2011168_CR107","volume-title":"National Cancer Intelligence Network","author":"L Elliss-Brookes","year":"2010","unstructured":"Elliss-Brookes, L. et al. Routes to Diagnosis: NCIN Data Briefing. National Cancer Intelligence Network [online] , (2010)."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.168","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T21:05:51Z","timestamp":1686431151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2011.168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFnrneph2011168"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2011.168","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}